Literature DB >> 27326188

A meta-analysis of proinflammatory cytokines in chronic heart failure.

Mao Liu1, Jian Chen1, Dan Huang1, Jianting Ke2, Wei Wu1.   

Abstract

BACKGROUND: Previous studies suggested that inflammation was involved in chronic heart failure (CHF), but their sample sizes were small.
OBJECTIVE: To summarise the clinical cytokine data systematically and emphasise the importance of proinflammatory cytokines in the pathogenesis of CHF, we conducted a meta-analysis of relevant literatures.
METHODS: Articles about cytokines and CHF were searched in Pubmed, EMBASE, Cochrane Library, Chinese National Knowledge Infrastructure and Chinese Wanfang Database. The pooled effects were measured by weighted mean difference (MD) and 95% CI, which were calculated by RevMan 5.1 software.
RESULTS: Finally, a total of 28 studies were included. Compared with normal control subjects, concentrations of tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β and C reactive protein (CRP) in the peripheral blood in CHF patients are significantly increased. The overall MDs with 95% CIs for TNF-α, IL-6, CRP and IL-1β were 2.59 pg/ml (2.14∼3.05, p<0.00001), 5.49 pg/mL (4.68∼6.29, p<0.00001), 11.45 mg/dL (7.68∼15.23, p<0.00001) and 0.11 pg/mL (0.09∼0.14, p<0.00001). The mortality of elevated IL-6 group was significantly higher than control group (OR=6.73, 95% CI 2.39∼18.93, p=0.0003).
CONCLUSIONS: Concentrations of TNF-α, IL-6, IL-1β and CRP are significantly higher in CHF patients than in control subjects. Proinflammatory cytokines play an import role in the pathogenesis of CHF.

Entities:  

Keywords:  HEART FAILURE

Year:  2014        PMID: 27326188      PMCID: PMC4832715          DOI: 10.1136/heartasia-2013-010484

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  37 in total

Review 1.  Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.

Authors:  Liu Mao; Chen Jian; Liu Changzhi; Huang Dan; Huang Suihua; Tang Wenyi; Wu Wei
Journal:  Arch Cardiovasc Dis       Date:  2013-09-27       Impact factor: 2.340

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

Authors:  M Rauchhaus; V Koloczek; H Volk; M Kemp; J Niebauer; D P Francis; A J Coats; S D Anker
Journal:  Int J Cardiol       Date:  2000 Nov-Dec       Impact factor: 4.164

4.  Prognostic value of serum cytokines in patients with congestive heart failure.

Authors:  J Orús; E Roig; F Perez-Villa; C Paré; M Azqueta; X Filella; M Heras; G Sanz
Journal:  J Heart Lung Transplant       Date:  2000-05       Impact factor: 10.247

5.  The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia.

Authors:  R V Milani; M R Mehra; S Endres; A Eigler; E S Cooper; C J Lavie; H O Ventura
Journal:  Chest       Date:  1996-10       Impact factor: 9.410

6.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

7.  Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.

Authors:  V Lubrano; A Pingitore; A Carpi; G Iervasi
Journal:  Biomed Pharmacother       Date:  2009-10-27       Impact factor: 6.529

8.  Inflammatory mediators in Chinese patients with congestive heart failure.

Authors:  Yongqing Wang; Yanli Zhou; Ling Meng; Xinzheng Lu; Ning Ou; Xinli Li
Journal:  J Clin Pharmacol       Date:  2009-05       Impact factor: 3.126

9.  Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients.

Authors:  Espen Haugen; Li-Ming Gan; Azra Isic; Tomas Skommevik; Michael Fu
Journal:  Exp Clin Cardiol       Date:  2008

10.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  8 in total

1.  Characterizing shared and distinct symptom clusters in common chronic conditions through natural language processing of nursing notes.

Authors:  Theresa A Koleck; Maxim Topaz; Nicholas P Tatonetti; Maureen George; Christine Miaskowski; Arlene Smaldone; Suzanne Bakken
Journal:  Res Nurs Health       Date:  2021-10-12       Impact factor: 2.228

2.  Predict, prevent and manage moral injuries in Canadian frontline healthcare workers and leaders facing the COVID-19 pandemic: Protocol of a mixed methods study.

Authors:  Mahée Gilbert-Ouimet; Azita Zahiriharsini; Caroline Biron; Lyse Langlois; Caroline Ménard; Manon Lebel; Jérôme Pelletier; Caroline Duchaine; Marianne Beaulieu; Manon Truchon
Journal:  SSM Ment Health       Date:  2022-06-01

Review 3.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

Review 4.  A Review of the Pharmacological Management of Chronic Pain in Patients with Heart Failure.

Authors:  Muhammad Hassan Majeed; Ali Ahsan Ali; Hafiza Ayesha Khalil; Douglas Bacon; Hafiz Muhammad Imran
Journal:  Innov Clin Neurosci       Date:  2019-11-01

Review 5.  Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Aleksandar Petrovic; Djuro Kosanovic; Akpay S Sarybaev; Norbert Weissmann; Hossein A Ghofrani; Ralph T Schermuly
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

6.  Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.

Authors:  Tobias Borchert; Annika Hess; Mario Lukačević; Tobias L Ross; Frank M Bengel; James T Thackeray
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-03       Impact factor: 9.236

7.  Inflammation and its association with oxidative stress in dogs with heart failure.

Authors:  Alenka Nemec Svete; Barbara Verk; Nina Čebulj-Kadunc; Janez Salobir; Vida Rezar; Aleksandra Domanjko Petrič
Journal:  BMC Vet Res       Date:  2021-04-26       Impact factor: 2.741

Review 8.  The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the Suppression of Intimal Hyperplasia: An Evidence-Based Review.

Authors:  Rohaina Che Man; Nadiah Sulaiman; Mohamad Fikeri Ishak; Ruszymah Bt Hj Idrus; Mohd Ramzisham Abdul Rahman; Muhammad Dain Yazid
Journal:  Int J Environ Res Public Health       Date:  2020-10-26       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.